Sign in
CompletedNo phase

Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users

Key facts

Who runs it
Wake Forest University Health Sciences
Where
Winston-Salem, United StatesSee the site
Trial code
Status
Completed
People taking part
147 people enrolled
Started
26 May 2020
Ended
9 Feb 2026
Type of study
Interventional, 4 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Real TBS to the vmPFC
  • Sham TBS to the vmPFC
  • Real TBS to the dlPFC
  • Sham TBS to the dlPFC
Record updated
2 June 2026

Who can take part

Age
21 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age 21- 75
  • Meets the DSM V criteria for having a current AUD, determined by DSM-V criteria, using the Structured Clinical Interview for DSM-V
  • Has an AUDIT score above 8 (such that they are at least Medium Risk drinkers according to criteria)

Who cannot take part

  • Is currently taking or initiates a medication known to affect alcohol intake and/or craving (e.g., disulfiram. naltrexone, acamprosate, topiramate). [Note: This exclusionary criterion is for scientific rather than safety or patient comfort reasons]
  • Expects a change in their medical history in the next 6 months that would impair their participation in this study [e.g. expected medical procedure, planned pregnancy, initiation of new medication]
  • Meets DSM V criteria for schizoaffective disorder. [Note: The inclusion of subjects with affective and anxiety disorders is essential because of the marked frequency of the co-existence of mood and other anxiety disorders among patients with AUD at large
  • Is at elevated risk of seizure (i.e., has a history of seizures, is currently prescribed medications known to lower seizure threshold and has had a change in their medication)
  • Is currently enrolled in another form of treatment for alcohol use disorder (This is for scientific reasons to clarify the role of TMS as a treatment agent)
  • History of traumatic brain injury resulting in hospitalization, loss of consciousness for more than 10 minutes, and/or having ever been informed he/she has an epidural, subdural, or subarachnoid hemorrhage
  • Any psychoactive substance use (except marijuana and nicotine) within the last 30 days by self-report
  • Has current suicidal ideation or homicidal ideation
  • Females of childbearing potential who are pregnant (by urine HCG), planning to become pregnant, nursing, or who are not using a reliable form of birth control
  • Suffers from chronic migraines (more than 50% of the days in a month)
  • Does not meet safety criteria for MRI and TMS
  • Not able to read and understand questionnaires, assessments, and the informed consent
  • Clinical Intake Withdrawal Assessment (CIWA) >5 (to prevent delivering TMS to individuals in withdrawal

Where in United States

  • Wake Forest School of MedicineWinston-Salem, United States

About the trial

What the trial wants to find out

There is growing interest in the utilization of transcranial magnetic stimulation (TMS) as a novel, non-pharmacologic approach to decreasing alcohol use among treatment-seeking individuals with Alcohol Use Disorder (AUD). The results of this study will be used to determine which of the 2 proposed TMS strategies has a larger effect on drinking behavior (% days abstinent, % heavy drinking days) as well as alcohol cue-reactivity in a 4 month period. These data will pave the way for TMS to be used as an innovative, new treatment option for individuals with AUD.

The 4 groups in the trial

  • Real TBS to the mPFCTreatment being tested

    Thirty sessions of real Theta Burst Stimulation (TBS) will be delivered to the left medial prefrontal cortex (mPFC)

    Treatment: Real TBS to the vmPFC

  • Sham TBS to the mPFCSham treatment, for comparison

    Thirty sessions of sham Theta Burst Stimulation (TBS) will be delivered to the left medial prefrontal cortex (mPFC)

    Treatment: Sham TBS to the vmPFC

  • Real TBS to the dlPFCTreatment being tested

    Thirty sessions of real Theta Burst Stimulation (TBS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC)

  • Sham TBS to the dlPFCSham treatment, for comparison

    Thirty sessions of sham Theta Burst Stimulation (TBS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
2 June 2026